FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

66703011000036100: Mylanta Double Strength reformulation (aluminium hydroxide 400 mg / 5 mL + magnesium hydroxide 400 mg / 5 mL + simethicone 30 mg / 5 mL) oral liquid, 200 mL (trade product pack)


Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2733251000168117 Mylanta Double Strength reformulation oral liquid, 200 mL en Synonym Active Case sensitive Australian Medicines Terminology module
2736171000168113 Mylanta Double Strength reformulation (aluminium hydroxide 400 mg / 5 mL + magnesium hydroxide 400 mg / 5 mL + simethicone 30 mg / 5 mL) oral liquid, 200 mL (trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mylanta Double Strength reformulation oral liquid, 200 mL Is a trade product pack true Inferred relationship Some
Mylanta Double Strength reformulation oral liquid, 200 mL Is a aluminium hydroxide 400 mg/5 mL + magnesium hydroxide 400 mg/5 mL + simethicone 30 mg/5 mL oral liquid, 200 mL true Inferred relationship Some
Mylanta Double Strength reformulation oral liquid, 200 mL has TPUU Mylanta Double Strength reformulation oral liquid, 5 mL true Inferred relationship Some 1
Mylanta Double Strength reformulation oral liquid, 200 mL has TP Mylanta Double Strength true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Mylanta Double Strength reformulation oral liquid, 200 mL, bottle Is a True Mylanta Double Strength reformulation oral liquid, 200 mL Inferred relationship Some

Reference Sets

Trade product pack reference set

Back to Start